Life Sciences Tools and Services
Company Overview of MetaMorphix, Inc.
MetaMorphix, Inc., a life sciences company, develops a pipeline of products and tests that addresses livestock sectors and enhances the health of companion animals. Its products engages in addressing various livestock sectors, including cattle, swine, poultry, and aquaculture; and engages in discovering and licensing targets to pharmaceutical companies that develop therapies for better management of metabolic and muscular degenerative diseases. MetaMorphix, Inc. was formerly known as Trophix, Inc. and changed its name to MetaMorphix, Inc. in June 1995. The company was founded in 1994 and is based in Beltsville, Maryland. It has a subsidiary location in Davis, California. As of March 18, 2011...
8000 Virginia Manor Road
Beltsville, MD 20705
Founded in 1994
Key Executives for MetaMorphix, Inc.
Chief Financial Officer, Principal Accounting Officer, Executive Vice President and Treasurer
Chief of Operations and Executive Vice President
Vice President of Genomic Research and Development
Director of Software Development and Bioinformatics
Compensation as of Fiscal Year 2016.
MetaMorphix, Inc. Key Developments
SEC Orders Hearing On Registration Suspension Or Revocation Against MetaMorphix Inc. For Failure To Make Required Periodic Filings
Mar 17 16
Securities and Exchange Commission (SEC or the commission) instituted public administrative proceeding to determine whether to revoke or suspend for a period not exceeding twelve months the registration of each class of the securities of MetaMorphix Inc. for failure to make required periodic filings with the Commission. In this Order, the Division of Enforcement (Division) alleges that the company was delinquent in its required periodic filings with the Commission. In this proceeding, instituted pursuant to Exchange Act Section 12(j), a hearing will be scheduled before an Administrative Law Judge. At the hearing, the judge will hear evidence from the Division and the company to determine whether the allegations of the Division contained in the Order, which the Division alleges constitute failures to comply with Exchange Act Section 13(a) and Rules 13a-1 and 13a-13 there under, are true. The judge in the proceeding will then determine whether the registrations pursuant to Exchange Act Section 12 of each class of the securities of the company should be revoked or suspended for a period not exceeding twelve months. The Commission ordered that the Administrative Law Judge in this proceeding issue an initial decision not later than 120 days from the date of service of the order instituting proceeding.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries